Collegium Pharmaceutical (COLL)
NASDAQ:COLL
Holding COLL?
Track your performance easily

Collegium Pharmaceutical (COLL) Ownership - Who Owns Collegium Pharmaceutical?

463 Followers

Collegium Pharmaceutical (COLL) Ownership Overview

4.12%36.39%9.36%33.70%16.43%
9.36% Other Institutional Investors
33.70% ETFs
16.43% Public Companies and
Individual Investors
The ownership structure of Collegium Pharmaceutical (COLL) stock is a mix of institutional, retail, and individual investors. Approximately 79.45% of the company’s stock is owned by Institutional Investors, 4.12% is owned by Insiders, and 16.43% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Sep 17, 2024
Thomas B Smith
Evp And Chief Medical Officer
xxxxxxxxxxxxx
$351296
Sep 06, 2024
xxxxxxxxxxxxx
$773781
May 28, 2024
Scott Dreyer
Evp & Cco
xxxxxxxxxxxxx
$3662190
May 16, 2024
Garen Bohlin
Director
xxxxxxxxxxxxx
$936216

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
3,887,662Institution12.07%125,027,210
2,629,593Institution8.16%84,567,711
2,535,932Institution7.87%81,555,573
1,980,156Institution6.15%63,681,817
1,495,495Institution4.64%48,095,119
1,135,464Institution3.52%36,516,522
685,176Institution2.13%22,035,260
643,982Institution2.00%20,710,461
593,047Institution1.84%19,072,392
463,364Institution1.44%14,901,786

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,629,593Institution8.16%84,567,711
1,495,495Institution4.64%48,095,119
1,135,464Institution3.52%36,516,522
685,176Institution2.13%22,035,260
643,982Institution2.00%20,710,461
463,364Institution1.44%14,901,786
363,071Institution1.13%11,676,363
342,319Institution1.06%11,008,979
316,301Institution0.98%10,172,240
315,755Institution0.98%10,154,681

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
2,536,490Institution7.87%88,041,568
2,056,696Institution6.38%66,143,343
993,931Institution3.09%38,405,494
880,442Institution2.73%28,315,015
472,896Institution1.47%18,272,701
312,336Institution0.97%10,044,726
288,585Institution0.90%10,016,785
290,138Institution0.90%9,330,838
193,975Institution0.60%6,238,236
174,972Institution0.54%6,073,278

FAQ

Who Owns Collegium Pharmaceutical (COLL)?
According to the latest TipRanks data, approximately 9.36% of the company's stock is held by institutional investors, 4.12% is held by insiders, and 16.43% is held by retail investors.
    What percentage of Collegium Pharmaceutical (COLL) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 9.36% of Collegium Pharmaceutical (COLL) stock is held by institutional investors.
      What percentage of Collegium Pharmaceutical (COLL) stock is held by retail investors?
      According to the latest TipRanks data, approximately 16.43% of Collegium Pharmaceutical (COLL) stock is held by retail investors.
        Who owns the most shares of Collegium Pharmaceutical (COLL)?
        iShares owns the most shares of Collegium Pharmaceutical (COLL).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis